Failure of a Mycobacterium tuberculosis ΔRD1 ΔpanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: Comparisons to responses elicited by M. bovis bacille Calmette Guerin

Vaccine

Volumn 25, Issue 45, 2007, Pages 7832-7840

  Waters, W Ray ^a   Palmer, Mitchell V ^a   Nonnecke, Brian J ^a   Thacker, Tyler C ^a   Scherer, Charles F Capinos ^b   Estes, D Mark ^b   Jacobs Jr , William R ^c   Glatman Freedman, Aharona ^c   Larsen, Michelle H ^c  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Aerosol Inoculation; Auxotroph; BCG; FoxP3; Live bacterial vaccine; Neonatal calf; Tuberculosis

Indexed keywords

ANTIGEN; BCG VACCINE; GAMMA INTERFERON; HERMES ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PANTOTHENIC ACID; TRANSCRIPTION FACTOR FOXP3;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BCG VACCINATION; CALF (BOVINE); CONTROLLED STUDY; DELETION MUTANT; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MONONUCLEAR CELL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INDUCTION; SENSITIZATION;

AEROSOLS; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CATTLE; CELLS, CULTURED; GENE DELETION; LEUKOCYTES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION;

EID: 35348979732     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.029     Document Type: Article

References (34)

1. Kaufman S.H.E. Is the development of a new tuberculosis vaccine possible?. Nat Med 6 9 (2000) 955-960
2. Walsh G.P., Tan E.V., dela Cruz E.C., Abalos R.M., Villahermosa L.G., Young L.J., et al. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med 2 4 (1996) 430-436
3. Rook G.A., Dheda K., and Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol 5 8 (2005) 661-667
4. Buddle B.M., Wedlock D.N., Parlane N.A., Corner L.A., De Lisle G.W., and Skinner M.A. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun 71 11 (2003) 6411-6419
5. Hope J.C., Thom M.L., Villarreal-Ramos B., Vordermeier H.M., Hewinson R.G., and Howard C.J. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin Exp Immunol 139 1 (2005) 48-56 [erratum in: Exp Immunol 2005;140(1):192]
6. Nonnecke B.J., Waters W.R., Foote M.R., Palmer M.V., Miller B.L., Johnson T.E., et al. Development of an adult-like cell-mediated immune response in calves after early vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Dairy Sci 88 (2005) 195-210
7. Foote M.R., Nonnecke B.J., Beitz D.C., and Waters W.R. High growth rate fails to enhance adaptive immune responses of neonatal calves and is associated with reduced lymphocyte viability. J Dairy Sci 90 (2007) 404-417
8. Cleaveland S., Shaw D.J., Mfinanga S.G., Shirima G., Kazwala R.R., Eblate E., et al. Mycobacterium bovis in rural Tanzania: risk factors for infection in human and cattle populations. Tuberculosis (Edinb) 87 1 (2007) 30-43
9. Winters A., Driver C., Macaraig M., Clark C., Munsiff S.S., Pichardo C., et al. Human tuberculosis caused by Mycobacterium bovis - New York City, 2001-2004. Morbid Mortal Wkly Rep 54 (2005) 605-608
10. Pym A.S., Brodin P., Brosch R., Huerre M., and Cole S.T. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 46 3 (2002) 709-717
11. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9 5 (2003) 533-539
12. Lewis K.N., Liao R., Guinn K.M., Hickey M.J., Smith S., Behr M.A., et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 187 1 (2003) 117-123
13. Hsu T., Hingley-Wilson S.M., Chen B., Chen M., Dai A.Z., Morin P.M., et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 100 21 (2003) 12420-12425
14. Sambandamurthy V.K., and Jacobs Jr. W.R. Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis. Microbes Infect 7 5-6 (2005) 955-961
15. Sambandamurthy V.K., Wang X., Chen B., Russell R.G., Derrick S., Collins F.M., et al. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med 8 10 (2002) 1171-1174
16. Sambandamurthy V.K., Derrick S.C., Hsu T., Chen B., Larsen M.H., Jalapathy K.V., et al. Mycobacterium tuberculosis ΔRD1 ΔpanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24 37-39 (2006) 6309-6320
17. Schmitt S.M., Fitzgerald S.D., Cooley T.M., Bruning-Fann C.S., Sullivan L., Berry D., et al. Bovine tuberculosis in free-ranging white-tailed deer from Michigan. J Wildl Dis 33 4 (1997) 749-758
18. Palmer M.V., Waters W.R., and Whipple D.L. Aerosol delivery of virulent Mycobacterium bovis to cattle. Tuberculosis (Edinb) 82 6 (2002) 275-282
19. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., and Hewinson R.G. Correlation of ESAT-6 specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70 6 (2002) 3026-3032
20. Rhoades E.R., Frank A.A., and Orme I.M. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 78 (1997) 57-66
21. + cells. J Comp Pathol 133 (2005) 223-234
22. Maue A.C., Waters W.R., Palmer M.V., Whipple D.L., Minion F.C., Brown W.C., et al. CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis. Vaccine 23 6 (2004) 769-779
23. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics methods and protocols: methods in molecular biology (2000), Humana Press, Totowa, NJ 365
24. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 4 (2001) 402-408
25. Waters W.R., Rahner T.E., Palmer M.V., Cheng D., Nonnecke B.J., and Whipple D.L. Expression of l-selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infect Immun 71 1 (2003) 317-326
26. Glatman-Freedman A., Martin J.M., Riska P.F., Bloom B.R., and Casadevall A. Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J Clin Microbiol 34 (1996) 2795-2802
27. Dietrich J., Aagaard C., Leah R., Olsen A.W., Stryhn A., Doherty T.M., et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 174 10 (2005) 6332-6339
28. Brown W.C., Rice-Ficht A.C., and Estes D.M. Bovine type 1 and type 2 responses. Vet Immunol Immunopathol 63 1-2 (1998) 45-55
29. Estes D.M., and Brown W.C. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet Immunol Immunopathol 90 1-2 (2002) 1-10
30. Chen X., Zhou B., Li M., Deng Q., Wu X., Le X., et al. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123 1 (2007) 50-59
31. Rook G.A., Hernandez-Pando R., Dheda K., and Teng Seah G. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol 25 9 (2004) 483-488 [review]
32. Wu B., Huang C., Kato-Maeda M., Hopewell P.C., Daley C.L., Krensky A.M., et al. Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease. J Immunol 178 6 (2007) 3688-3694
33. Guyot-Revol V., Innes J.A., Hackforth S., Hinks T., and Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173 7 (2006) 803-810
34. Briken V., Porcelli S.A., Besra G.S., and Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 53 (2004) 391-403